semaglutide for hfpef VisualAbstract: improves symptoms in patients with heart failure Semaglutide in Patients with Heart

Full disclosure of medical history is essential, including any history of seizures, eating disorders, cardiovascular disease, liver or kidney impairment, diabetes, thyroid disorders, or mental health conditions

Not all individuals exposed to stress or adversity go on to develop anxiety disorders (Charney, 2003)

In the year following discontinuation of semaglutide or liraglutide, patients with class 3 obesitya BMI of 40 or greaterwhen starting a GLP-1 medication were much more likely to maintain or lose additional weight compared to those who started treatment with a healthy weighta BMI between 18.5 and 25

To dissect the biochemical derangements imposed by chronic hyperglycaemia, a three-dimensional, tissue-engineered wound model has been engineered that faithfully recapitulates the accumulation of AGEs and the attendant impairment of fibroblast proliferation, angiogenic signaling, and extracellular-matrix turnover that underlie the stalled diabetic repair program (129)